Markets:

Overview

News

Currencies

International

Treasuries

Kenvue Inc. Common Stock (NY:KVUE)

16.84 -0.09 (-0.53%)

Streaming Delayed Price Updated: 11:32 AM EST, Dec 8, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Kenvue Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

25 26 Next >

Tylenol Turmoil: Partisan Politics Fuel Confusion Over Pregnancy Risks, Poll Shows ↗

October 10, 2025

KFF poll shows falling trust in the CDC and HHS chief RFK Jr. as misinformation and partisan divides shape public views on vaccines.

Via Benzinga

Is This Beaten-Down Dividend King a Buy? ↗

October 10, 2025

This company's short life on the stock market has been a constant challenge.

Via The Motley Fool

Topics Intellectual Property

Which S&P500 stocks are moving on Thursday? ↗

October 09, 2025

Curious about the top performers within the S&P500 index one hour before the close of the markets on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive...

Via Chartmill

Stocks Ease, Delta Air Lines, Pepsi Jump On Strong Earnings: What's Moving Markets Thursday? ↗

October 09, 2025

U.S. stocks edged lower on Thursday, pausing after a record-setting run. The S&P 500 slipped 0.4% by midday in New York, retreating from an all-time high of 5,674 hit at the open.

Via Benzinga

Kenvue Stock To Face More Headwinds? Trump’s Tylenol Warning Revives Autism Lawsuits, Retail Bulls Stay Unfazed ↗

September 24, 2025

Via Stocktwits

Topics Government Lawsuit

Why Is Kenvue Stock Rising Premarket Today? ↗

September 24, 2025

Via Stocktwits

Discover which S&P500 stocks are making waves on Thursday. ↗

October 09, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Thursday.

Via Chartmill

These Were the 5 Worst-Performing Stocks in the S&P 500 in September 2025 -- and One's Decline Can Be Tied to President Trump ↗

October 08, 2025

One of these stocks lost about a quarter of its value in a single month.

Via The Motley Fool

Topics Government Stocks World Trade

Near 52-Week Low, Should You Buy Kenvue Stock? ↗

October 08, 2025

This beaten-down stock could be an attractive option for long-term investors.

Via The Motley Fool

Discover which S&P500 stocks are making waves on Tuesday. ↗

October 07, 2025

Get insights into the S&P500 index performance on Tuesday. Explore the top gainers and losers within the S&P500 index in today's session.

Via Chartmill

Stocks, Bitcoin Slip, Gold Hits $4,000: What's Moving Markets Tuesday? ↗

October 07, 2025

Risk sentiment is taking a breather after days of a relentless rally, with all major Wall Street indexes trading in negative territory and sharper declines hitting the most speculative assets, such as...

Via Benzinga

Exploring the top movers within the S&P500 index during today's session. ↗

October 07, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Tuesday.

Via Chartmill

Why Is Kenvue Stock Falling, and Is It a Buying Opportunity? ↗

October 07, 2025

Investors are interested in this beaten-down business.

Via The Motley Fool

Options Corner: Despite Political Woes, Kenvue Can Still Make Tylenol Great Again ↗

October 06, 2025

While Kenvue's Tylenol has attracted intense political pressure, speculators are determined to make KVUE stock great again.

Via Benzinga

A Congress Member Sold Up To $330K In UnitedHealth Group Stock: Here's What You Need To Know ↗

October 06, 2025

Via Benzinga

Should You Buy Kenvue Stock After Its 30% Plunge? ↗

October 01, 2025

There hasn't been much good news lately for this Johnson & Johnson spinoff.

Via The Motley Fool

Topics Government Lawsuit

Cullen Trims KVUE Stake With $149.5M Share Sale ↗

October 01, 2025

Via The Motley Fool

Topics Regulatory Compliance

Friday's session: most active stock in the S&P500 index ↗

September 26, 2025

Looking for the most active S&P500 stocks in today's session? Join us as we dive into the US markets on Friday and discover the stocks that are dominating the trading activity and setting the pace for...

Via Chartmill

Demystifying Kenvue: Insights From 11 Analyst Reviews ↗

September 26, 2025

Kenvue (NYSE: KVUE) underwent analysis by 11 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. In the table below, you'll find a summary of their recent ratings,...

Via Benzinga

White House Highlights A Controversial 2017 Tylenol Tweet On Its Usage During Pregnancy: 'We Actually Don't Recommend...' ↗

September 26, 2025

A 2017 post by Tylenol on X (formerly Twitter) highlighted by White House has fueled a buzz around President Donald Trump‘s claim that the drug is linked with autism in kids.

Via Benzinga

Kenvue Bounces Off Record Low: A Deep Dive into its Rebound and Future Prospects

September 24, 2025

Kenvue (NYSE: KVUE), the consumer health giant spun off from Johnson & Johnson, has experienced a significant rebound in its stock price, climbing notably from a recent record low. This resurgence...

Via MarketMinute

Topics Government Product Recall

What's going on in today's session: S&P500 movers ↗

September 24, 2025

Stay informed about the performance of the S&P500 index one hour before the close of the markets on Wednesday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

Wednesday's session: most active stock in the S&P500 index ↗

September 24, 2025

Looking for the most active S&P500 stocks in today's session? Join us as we dive into the US markets on Wednesday and discover the stocks that are dominating the trading activity and setting the pace...

Via Chartmill

Kenvue Surges Over 2% Pre-Market Despite Trump Administration's Autism Warning ↗

September 24, 2025

Kenvue's stock rose 2.61% to $17.69 in pre-market trading on Wednesday, despite concerns sparked by President Trump's comments linking acetaminophen to autism.

Via Benzinga

Topics Government

Jon Stewart Roasts Trump Over 'Acetaminophen' Pronunciation: 'We Would Like A Second Opinion' ↗

September 24, 2025

Trump struggles to pronounce acetaminophen while warning pregnant women of its potential link to autism. Jon Stewart mocks his incompetence.

Via Benzinga

Topics Government

Nvidia, Plug Power, Micron, Kenvue, Kroger: What Sparked Heavy After-Hours Trading In These 5 Stocks? ↗

September 23, 2025

Micron stock showed a muted reaction to earnings despite the quarterly numbers and guidance exceeding expectations.

Via Stocktwits

Topics Artificial Intelligence

Trump’s Tylenol Warning Sparks FDA Action, But Kenvue Stock Climbs: Retail Traders See ‘Huge Buying Opportunity’ ↗

September 23, 2025

Kenvue is facing renewed litigation risks, activist investor pressure, and a challenging consumer backdrop as it undertakes a portfolio review under interim CEO Kirk Perry.

Via Stocktwits

Topics Economy Government Lawsuit

These S&P500 stocks are the most active in today's session ↗

September 23, 2025

Curious about the most active S&P500 stocks in today's session? Join us as we explore the US markets on Tuesday and uncover the stocks that are leading the way in terms of trading volume and market...

Via Chartmill

Curious about which S&P500 stocks are generating unusual volume on Tuesday? Find out below. ↗

September 23, 2025

In today's session, there are S&P500 stocks with remarkable trading volume. Explore the stocks exhibiting unusual volume in Tuesday's session.

Via Chartmill

What's Going On With Kenvue Stock Tuesday? ↗

September 23, 2025

Kenvue shares are trading higher Tuesday despite Trump saying the Food and Drug Administration will notify physicians that use of acetaminophen or Tylenol during pregnancy could be associated with...

Via Benzinga

Topics Government

< Previous 1 2 3 4 5 6 7 8 9

...

25 26 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.